Vaxcyte, Inc. PCVX Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s common stock, par value (in dollars per share)?
- Vaxcyte, Inc. (PCVX) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Vaxcyte, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Vaxcyte, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Vaxcyte, Inc.'s common stock, par value (in dollars per share)?
- Over 2 years (2023 to 2025), Vaxcyte, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.